Annual Cash & Cash Equivalents
$6.45 M
-$21.16 M-76.63%
December 1, 2023
Summary
- As of March 6, 2025, GOVX annual cash & cash equivalents is $6.45 million, with the most recent change of -$21.16 million (-76.63%) on December 1, 2023.
- During the last 3 years, GOVX annual cash & cash equivalents has fallen by -$3.43 million (-34.72%).
- GOVX annual cash & cash equivalents is now -76.63% below its all-time high of $27.61 million, reached on December 31, 2022.
Performance
GOVX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.59 M
+$7.03 M+450.20%
September 1, 2024
Summary
- As of March 6, 2025, GOVX quarterly cash and cash equivalents is $8.59 million, with the most recent change of +$7.03 million (+450.20%) on September 1, 2024.
- Over the past year, GOVX quarterly cash and cash equivalents has stayed the same.
- GOVX quarterly cash and cash equivalents is now -75.22% below its all-time high of $34.68 million, reached on September 30, 2022.
Performance
GOVX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GOVX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.6% | 0.0% |
| 3 y3 years | -34.7% | -52.5% |
| 5 y5 years | +2384.6% | -25.8% |
GOVX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.6% | at low | -75.2% | +1017.5% |
| 5 y | 5-year | -76.6% | +2177.7% | -75.2% | +3774.0% |
| alltime | all time | -76.6% | >+9999.0% | -75.2% | >+9999.0% |
GeoVax Labs Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.59 M(+450.2%) |
| Jun 2024 | - | $1.56 M(+103.1%) |
| Mar 2024 | - | $768.90 K(-88.1%) |
| Dec 2023 | $6.45 M(-76.6%) | $6.45 M(-49.1%) |
| Sep 2023 | - | $12.69 M(-28.7%) |
| Jun 2023 | - | $17.79 M(-25.4%) |
| Mar 2023 | - | $23.85 M(-13.6%) |
| Dec 2022 | $27.61 M(+141.7%) | $27.61 M(-20.4%) |
| Sep 2022 | - | $34.68 M(+12.2%) |
| Jun 2022 | - | $30.90 M(+90.1%) |
| Mar 2022 | - | $16.26 M(+42.3%) |
| Dec 2021 | $11.42 M(+15.6%) | $11.42 M(-36.9%) |
| Sep 2021 | - | $18.11 M(-7.3%) |
| Jun 2021 | - | $19.54 M(-6.3%) |
| Mar 2021 | - | $20.84 M(+110.9%) |
| Dec 2020 | $9.88 M(+3388.8%) | $9.88 M(-14.7%) |
| Sep 2020 | - | $11.58 M(+1529.5%) |
| Jun 2020 | - | $710.70 K(+220.4%) |
| Mar 2020 | - | $221.80 K(-21.7%) |
| Dec 2019 | $283.30 K(+9.1%) | $283.30 K(-50.2%) |
| Sep 2019 | - | $569.40 K(+163.1%) |
| Jun 2019 | - | $216.40 K(+23.0%) |
| Mar 2019 | - | $176.00 K(-32.2%) |
| Dec 2018 | $259.70 K(-16.9%) | $259.70 K(-49.2%) |
| Sep 2018 | - | $511.20 K(+167.6%) |
| Jun 2018 | - | $191.00 K(-66.6%) |
| Mar 2018 | - | $571.20 K(+82.7%) |
| Dec 2017 | $312.70 K(-31.1%) | $312.70 K(-9.0%) |
| Sep 2017 | - | $343.80 K(-58.2%) |
| Jun 2017 | - | $822.60 K(+393.5%) |
| Mar 2017 | - | $166.70 K(-63.3%) |
| Dec 2016 | $454.00 K(-57.2%) | $454.00 K(-11.2%) |
| Sep 2016 | - | $511.10 K(+137.6%) |
| Jun 2016 | - | $215.10 K(-67.9%) |
| Mar 2016 | - | $669.50 K(-36.9%) |
| Dec 2015 | $1.06 M(-3.8%) | $1.06 M(-41.8%) |
| Sep 2015 | - | $1.82 M(-26.4%) |
| Jun 2015 | - | $2.48 M(-21.3%) |
| Mar 2015 | - | $3.15 M(+185.6%) |
| Dec 2014 | $1.10 M(-56.2%) | $1.10 M(+27.8%) |
| Sep 2014 | - | $862.20 K(-37.1%) |
| Jun 2014 | - | $1.37 M(-31.8%) |
| Mar 2014 | - | $2.01 M(-20.0%) |
| Dec 2013 | $2.51 M | $2.51 M(+46.1%) |
| Sep 2013 | - | $1.72 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $1.88 M(+7.4%) |
| Mar 2013 | - | $1.75 M(+69.1%) |
| Dec 2012 | $1.04 M(-11.3%) | $1.04 M(-34.6%) |
| Sep 2012 | - | $1.58 M(-12.8%) |
| Jun 2012 | - | $1.82 M(-18.9%) |
| Mar 2012 | - | $2.24 M(+91.8%) |
| Dec 2011 | $1.17 M(+8.2%) | $1.17 M(+106.1%) |
| Sep 2011 | - | $566.70 K(-15.2%) |
| Jun 2011 | - | $668.10 K(+23.3%) |
| Mar 2011 | - | $541.70 K(-49.8%) |
| Dec 2010 | $1.08 M(-69.3%) | $1.08 M(-24.3%) |
| Sep 2010 | - | $1.43 M(-21.1%) |
| Jun 2010 | - | $1.81 M(-30.6%) |
| Mar 2010 | - | $2.60 M(-26.0%) |
| Dec 2009 | $3.52 M(+60.5%) | $3.52 M(+2.9%) |
| Sep 2009 | - | $3.42 M(+87.4%) |
| Jun 2009 | - | $1.82 M(-7.5%) |
| Mar 2009 | - | $1.97 M(-10.0%) |
| Dec 2008 | $2.19 M(+10.1%) | $2.19 M(-21.3%) |
| Sep 2008 | - | $2.78 M(-11.1%) |
| Jun 2008 | - | $3.13 M(+47.8%) |
| Mar 2008 | - | $2.12 M(+6.5%) |
| Dec 2007 | $1.99 M(-4.7%) | $1.99 M(+171.9%) |
| Sep 2007 | - | $732.00 K(-27.5%) |
| Jun 2007 | - | $1.01 M(-41.1%) |
| Mar 2007 | - | $1.71 M(-18.0%) |
| Dec 2006 | $2.09 M(+64.1%) | $2.09 M(-19.4%) |
| Sep 2006 | - | $2.59 M(+2622.5%) |
| Jun 2006 | - | $95.10 K(+756.8%) |
| Mar 2006 | - | $11.10 K(-99.1%) |
| Dec 2005 | $1.27 M(>+9900.0%) | $1.27 M(>+9900.0%) |
| Dec 2004 | $7800.00(+2500.0%) | $7800.00(-83.9%) |
| Dec 2003 | $300.00(-99.0%) | - |
| Sep 2002 | - | $48.30 K(-28.4%) |
| Jun 2002 | - | $67.50 K(-71.4%) |
| Mar 2002 | - | $236.40 K(-23.2%) |
| Sep 2001 | - | $307.80 K(-59.3%) |
| Jun 2001 | - | $756.90 K(-60.8%) |
| Mar 2001 | - | $1.93 M(-14.6%) |
| Sep 2000 | - | $2.26 M(-43.7%) |
| Jun 2000 | - | $4.01 M(-5.0%) |
| Mar 2000 | - | $4.23 M |
| Dec 1999 | $31.10 K(-44.2%) | - |
| Dec 1998 | $55.70 K(-98.5%) | - |
| Dec 1997 | $3.62 M(+831.8%) | - |
| Dec 1996 | $388.60 K | - |
FAQ
- What is GeoVax Labs annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GeoVax Labs?
- What is GeoVax Labs annual cash & cash equivalents year-on-year change?
- What is GeoVax Labs quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GeoVax Labs?
- What is GeoVax Labs quarterly cash and cash equivalents year-on-year change?
What is GeoVax Labs annual cash & cash equivalents?
The current annual cash & cash equivalents of GOVX is $6.45 M
What is the all time high annual cash & cash equivalents for GeoVax Labs?
GeoVax Labs all-time high annual cash & cash equivalents is $27.61 M
What is GeoVax Labs annual cash & cash equivalents year-on-year change?
Over the past year, GOVX annual cash & cash equivalents has changed by -$21.16 M (-76.63%)
What is GeoVax Labs quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GOVX is $8.59 M
What is the all time high quarterly cash and cash equivalents for GeoVax Labs?
GeoVax Labs all-time high quarterly cash and cash equivalents is $34.68 M
What is GeoVax Labs quarterly cash and cash equivalents year-on-year change?
Over the past year, GOVX quarterly cash and cash equivalents has changed by $0.00 (0.00%)